Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
Primary and secondary metastatic dissemination: multiple routes to cancer-related death
D Sparrer1,2, R Blazquez3, F Keil4
1Center for Translational Oncology, University Hospital Regensburg, Regensburg, 93053, Germany.
Abstract:
Metastatic disease accounts for approximately 80% of cancer-related deaths, typically manifesting as single-organ failure mainly through abdominal, cardiovascular, neurological, or respiratory complications. Despite treating thousands of cancer patients daily worldwide, our understanding of organ-specific metastatic dissemination routes, tissue destruction mechanisms and reasons for organ failures remains limited. As cancer-directed therapies advance, maintaining organ function has emerged as a critical therapeutic goal of care. To develop more effective treatment strategies, a comprehensive understanding of the pathophysiology is essential, particularly regarding secondary and subsequent metastatic waves that lead to extensive macro-metastases and organ failure. Critical distinction between primary metastatic spread and secondary intra-organ dissemination is crucial. In the era of precision oncology, elucidating organ-specific destruction processes and the pathophysiology of metastatic waves is fundamental for advancing patient care. To highlight the emerging goal of care of maintaining organ function, we aligned the metastatic biology, clinical stages, goals of care and therapeutic indications: the Bio Therapeutic Goals of Cancer Care Model.
Insights
Metastatic cancer causes most cancer deaths, often leading to organ failure. Understanding organ-specific spread and destruction is key to developing new therapies that preserve organ function.
Area of Science:
- Oncology
- Pathophysiology
- Cancer Metastasis
Background:
- Metastatic disease is responsible for approximately 80% of cancer-related deaths.
- Organ failure, often due to abdominal, cardiovascular, neurological, or respiratory complications, is the primary cause of mortality.
- Current understanding of organ-specific metastatic routes and tissue destruction mechanisms remains limited.
Purpose of the Study:
- To enhance understanding of organ-specific metastatic dissemination and destruction.
- To elucidate the pathophysiology of secondary and subsequent metastatic waves.
- To highlight the emerging therapeutic goal of maintaining organ function in cancer care.
Main Methods:
- Literature review and synthesis of current research on metastatic biology.
- Analysis of clinical data related to metastatic disease progression and organ failure.
- Development of a conceptual model aligning metastatic biology with clinical goals of care.
Main Results:
- Distinguishing primary metastatic spread from secondary intra-organ dissemination is critical.
- Understanding organ-specific destruction processes is fundamental for advancing patient care.
- The Bio Therapeutic Goals of Cancer Care Model integrates metastatic biology, clinical stages, and therapeutic indications.
Conclusions:
- Maintaining organ function is an emerging critical therapeutic goal in cancer care.
- Elucidating the pathophysiology of metastatic waves is essential for developing effective treatments.
- The Bio Therapeutic Goals of Cancer Care Model provides a framework for aligning research and clinical practice.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

